ICAAC 2005

Which Macrolide Antibiotics Provide Greatest Barrier to Resistance in Streptococcus pneumoniae?

Joseph Blondeau
Joseph Blondeau

Antibiotic resistance is not going to go away in a hurry, but can we at least make it as difficult as possible for bacteria to overcome the drugs they face? Joseph Blondeau told the conference about his group’s investigation into which of three macrolide antibiotics was the most difficult for Streptococcus pneumoniae to develop resistance against.

Click here for all the interviews from ICAAC 2005

Similar Interviews

  • Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco">Audio Journal of Infectious Disease: Reporting from the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, San Francisco
  • Henry Fraimow

  • Pharmacokinetically Enhanced Amoxicillin and Clavulanate for Drug Resistant Streptococcus Pneumoniae
  • Thomas File Thomas File, Summa Health System, Akron, Ohio Community Associated Pneumonia is a sizeable problem for health systems, and what is

  • Chloroquine Selects for Fluoroquinolone Resistance in Guyana
  • Ross Davidson Ross Davidson, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia The use of the antimalarial chloroquine could provide the

    Post a comment

    Subscribe to Audio Medica Podcast